Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1981 Aug;56(8):637–640. doi: 10.1136/adc.56.8.637

Saliva carbamazepine and phenytoin level monitoring.

G W Rylance, T A Moreland
PMCID: PMC1627278  PMID: 7271302

Abstract

Saliva carbamazepine and phenytoin samples were used to monitor treatment in 35 children aged between 2 and 14 years during a 2-year period. All phenytoin levels and over half the carbamazepine levels that were above the therapeutic range were associated with adverse effects. Dose and carbamazepine saliva levels were significantly related but no such relationship was found for phenytoin. There was no apparent relationship between the saliva level of either drug and convulsion control.

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayers G. J., Burnett D. Drug formulation and salivary phenytoin measurements. Lancet. 1977 Mar 19;1(8012):656–656. doi: 10.1016/s0140-6736(77)92097-9. [DOI] [PubMed] [Google Scholar]
  2. Bartels H., Oldigs H. D., Günther E. Use of saliva in monitoring carbamazepine medication in epileptic children. Eur J Pediatr. 1977 Aug 23;126(1-2):37–44. doi: 10.1007/BF00443121. [DOI] [PubMed] [Google Scholar]
  3. Cook C. E., Amerson E., Poole W. K., Lesser P., O'Tuama L. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther. 1975 Dec;18(6):742–747. doi: 10.1002/cpt1975186742. [DOI] [PubMed] [Google Scholar]
  4. Least C. J., Jr, Johnson G. F., Solomon H. M. Therapeutic monitoring of anticonvulsant drugs: gas-chromatographic simultaneous determination of primidone, phenylethylmalonamide, carbamazepine, and diphenylhydantoin. Clin Chem. 1975 Oct;21(11):1658–1662. [PubMed] [Google Scholar]
  5. Robinson J. D., Morris B. A., Aherne G. W., Marks V. Pharmacokinetics of a single dose of phenytoin in man measured by radioimmunoassay. Br J Clin Pharmacol. 1975 Aug;2(4):345–349. doi: 10.1111/j.1365-2125.1975.tb02782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rylance G. W., Moreland T. A., Butcher G. M. Carbamazepine dose-frequency requirement in children. Arch Dis Child. 1979 Jun;54(6):454–458. doi: 10.1136/adc.54.6.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rylance G. W., Moreland T. A. Drug level monitoring in paediatric practice. Arch Dis Child. 1980 Feb;55(2):89–98. doi: 10.1136/adc.55.2.89. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES